Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson purchased 297 shares of the stock in a transaction on Friday, April 11th. The stock was acquired at an average cost of GBX 51 ($0.68) per share, for a total transaction of £151.47 ($201.40).
Giles Wilson also recently made the following trade(s):
- On Tuesday, March 25th, Giles Wilson purchased 32,640 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 54 ($0.72) per share, with a total value of £17,625.60 ($23,435.18).
- On Tuesday, March 11th, Giles Wilson purchased 269 shares of Dr. Martens stock. The stock was bought at an average price of GBX 56 ($0.74) per share, for a total transaction of £150.64 ($200.29).
- On Tuesday, February 11th, Giles Wilson bought 207 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 73 ($0.97) per share, with a total value of £151.11 ($200.92).
Dr. Martens Price Performance
Shares of DOCS stock traded up GBX 1.80 ($0.02) during trading hours on Friday, reaching GBX 52.80 ($0.70). 591,600 shares of the company were exchanged, compared to its average volume of 2,633,381. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. The company has a market cap of £512.56 million, a price-to-earnings ratio of 7.49, a P/E/G ratio of 6.40 and a beta of 0.11. The stock's fifty day moving average is GBX 57.34 and its two-hundred day moving average is GBX 62.39. Dr. Martens plc has a fifty-two week low of GBX 43.02 ($0.57) and a fifty-two week high of GBX 93.25 ($1.24).
Dr. Martens Cuts Dividend
The business also recently declared a dividend, which was paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th were given a GBX 0.85 ($0.01) dividend. The ex-dividend date was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's dividend payout ratio is currently 42.53%.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Recommended Stories
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
